BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Caplin Point Laboratories Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524742
ISIN Demat
INE475E01026
Book Value (Rs)
269.7614245
NSE Symbol
CAPLIPOINT
Divident Yield %
0.17
Market Cap
(Rs In Cr.)
17,967
P/E (TTM)
45.31
EPS (TTM)
52.17
Face Value
(Rs)
2
Back
Caplin Point Laboratories consolidated net profit rises 19.32% in the March 2026 quarter
14-May-26   Hrs IST

Net profit of Caplin Point Laboratories rose 19.32% to Rs 170.11 crore in the quarter ended March 2026 as against Rs 142.57 crore during the previous quarter ended March 2025. Sales rose 19.45% to Rs 600.16 crore in the quarter ended March 2026 as against Rs 502.45 crore during the previous quarter ended March 2025.

For the full year,net profit rose 19.57% to Rs 641.24 crore in the year ended March 2026 as against Rs 536.31 crore during the previous year ended March 2025. Sales rose 12.89% to Rs 2187.19 crore in the year ended March 2026 as against Rs 1937.47 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales600.16502.45 19 2187.191937.47 13
OPM %34.0333.45 -34.7933.39 -
PBDT232.24193.71 20 875.56742.74 18
PBT213.44176.67 21 802.79676.78 19
NP170.11142.57 19 641.24536.31 20

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)